Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

15.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K
Neural Regulation01:37

Neural Regulation

39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pembrolizumab-associated immune-related hepatitis: a retrospective case report analysis.

Frontiers in medicine·2026
Same author

DcLcyB1 and DcLcyB2, two lycopene β-cyclases with partial functional overlap modulate carotene profiles in carrot roots via distinct catalytic properties.

Molecular horticulture·2026
Same author

Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Systematic Review and Component Network Meta-Analysis.

Brain and behavior·2026
Same author

[Effects of Water and Nitrogen Addition on N and P Ecological Stoichiometry of Plant Functional Groups in an <i>Artemisia ordosica</i> Community].

Huan jing ke xue= Huanjing kexue·2026
Same author

A Janus-structured PVA/collagen membrane co-loaded with <i>Orthosiphon aristatus</i> extract and DMOG for diabetic wound healing.

Biomaterials science·2026
Same author

Top 100 most-cited articles on NLRP3 (2000-2024): a retrospective analysis.

Frontiers in immunology·2026

Related Experiment Video

Updated: Jul 28, 2025

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.7K

Progress in Research on CNPY2 in Diseases.

Ke-Qian Chen1,2, Yu-Qing Zhang1,2, Zong-Bao Wang1,2

  • 1Institute of Pharmacy and Pharmacology, School of Pharmaceutical Sciences, Hengyang Medical School, University of South China, Hengyang, 421001, China.

Mini Reviews in Medicinal Chemistry
|June 1, 2023
PubMed
Summary

Canopy FGF signaling regulator 2 (CNPY2) promotes angiogenesis in tumors and impacts neurologic and cardiovascular diseases. Further research into CNPY2

Keywords:
Canopy FGF signaling regulator 2cancercanopy FGF signaling regulator 1canopy FGF signaling regulator 3canopy FGF signaling regulator 4canopy FGF signaling regulator 5.cardiovascular diseasesneurologic diseasesnon-alcoholic fatty liver disease

More Related Videos

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
10:50

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Published on: April 24, 2021

1.1K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.0K

Related Experiment Videos

Last Updated: Jul 28, 2025

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.7K
Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
10:50

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Published on: April 24, 2021

1.1K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.0K

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Oncology
  • Cardiology
  • Neurology

Background:

  • Canopy FGF signaling regulator 2 (CNPY2) is identified as a novel angiogenic growth factor with emerging roles in various physiological and pathological processes.
  • CNPY2's involvement in promoting angiogenesis is crucial for tumor growth and has implications in other diseases, yet its functions and mechanisms remain underexplored.

Approach:

  • This review synthesizes recent studies investigating CNPY2's role across a spectrum of diseases, including various cancers, neurological disorders, and cardiovascular conditions.
  • The paper examines the biological functions and molecular mechanisms of CNPY2 in disease development and progression.
  • It also reviews therapeutic agents targeting CNPY2 for potential treatment applications.

Key Points:

  • CNPY2 promotes angiogenesis, essential for tumor growth, and influences neurite outgrowth in neurological diseases and cardiac function in cardiovascular diseases.
  • The review covers CNPY2's involvement in cervical, renal, prostate, colorectal, lung, gastric, and hepatocellular carcinomas, as well as cerebral and spinal cord ischemia-reperfusion injuries.
  • It also details CNPY2's role in Parkinson's disease, ischemic heart disease, myocardial infarction, heart failure, and non-alcoholic fatty liver disease.

Conclusions:

  • CNPY2 is a significant factor in tumor angiogenesis and various other diseases, with potential therapeutic targets identified.
  • Understanding CNPY2's precise biological functions and molecular mechanisms is crucial for future disease prevention and treatment strategies.
  • The study also briefly touches upon related family members: CNPY1, CNPY3, CNPY4, and CNPY5.